封面
市場調查報告書
商品編碼
2038599

全球不孕症治療市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Infertility Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球生育治療市場預計將從2025年的28.5億美元成長至2034年的60.2億美元,2026年至2034年的複合年成長率(CAGR)為8.68%。該市場正經歷快速成長,主要原因是全球男性和女性不孕症問題日益增加。生育延遲、生活方式改變、壓力和健康問題等因素都導致了生育率的上升。隨著各地區對生育治療的認知度和可近性的提高,輔助生殖技術、藥物療法和外科手術等治療方法方法正被更廣泛地接受。

體外受精等輔助生殖技術的進步、治療成功率的提高以及醫療保健成本的上漲是推動該市場成長的主要因素。人們對生育治療方案的認知度提高以及政府的支持措施,促使更多人尋求治療。此外,生育診所的擴張和先進診斷工具的廣泛應用也促進了市場成長。

展望未來,生殖醫學市場預計將持續創新,包括個人化治療方案和基因篩檢技術。社會對不孕症的接受度提高和歧視減少將進一步推動市場需求。拓展新興市場和提升成本效益也將對市場成長起到關鍵作用。預計未來幾年,不孕症治療市場將顯著成長。

我們的報告經過精心撰寫,旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分,旨在幫助您全面了解市場環境:

市場概覽:本節提供清晰的市場概覽,包括關鍵定義、分類和當前產業格局。

市場動態:對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析:本部分依據產品類型、應用、最終使用者和地區,將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局:我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為深入了解競爭動態和主要參與者所採取的策略提供了寶貴的見解。

市場預測:本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析,揭示未來預期趨勢。

區域分析:本部分全面回顧了主要地理區域的市場表現,確定了高成長領域和區域趨勢,從而更深入地了解區域市場機會。

新趨勢與新機會:識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項:我們提供靈活的客製化服務,可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察,以更好地支持您的策略決策。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球不孕症治療市場:依產品分類

  • 市場分析、洞察與預測
  • 設備(顯微鏡、影像系統、精子分析系統、卵子抽吸幫浦、顯微操作系統、培養箱、氣體分析儀、雷射系統、冷凍系統、精子分離裝置)
  • 媒體和耗材
  • 配件

第5章:全球不孕症治療市場:依手術類型分類

  • 市場分析、洞察與預測
  • 輔助生殖技術
  • 人工授精
  • 節育手術
  • 其他不孕症治療方法

第6章 全球不孕症治療市場:依患者類型分類

  • 市場分析、洞察與預測
  • 女性不孕症治療
  • 男性不孕症治療

第7章 全球不孕症治療市場:依最終用戶分類

  • 市場分析、洞察與預測
  • 不孕症治療中心
  • 醫院和外科診所
  • 冷凍保存庫
  • 研究機構

第8章 全球不孕症治療市場:按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第10章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • The Cooper Companies Inc
    • Cook Group
    • Vitrolife
    • Thermo Fisher Scientific Inc
    • Esco Micro Pte. Ltd
    • Genea Biomedx
    • IVFtech ApS
    • FUJIFILM Irvine Scientific
    • The Baker Company Inc
    • Kitazato Corporation
    • Rocket Medical Plc
    • IHMedical A/S
    • Hamilton Thorne Ltd
    • ZEISS Group
    • MedGyn Products Inc
簡介目錄
Product Code: VMR11211051

The global infertility treatment market size is expected to reach USD 6.02 Billion in 2034 from USD 2.85 Billion in 2025, growing at a CAGR of 8.68 during 2026-2034.This market is experiencing rapid growth due to the increasing prevalence of infertility issues among both men and women worldwide. Factors such as delayed parenthood, lifestyle changes, stress, and medical conditions are contributing to rising infertility rates. Treatments including assisted reproductive technologies, medications, and surgical procedures are gaining widespread acceptance as awareness and accessibility improve across various regions.

The market is driven by advancements in reproductive technologies such as in vitro fertilization, improved success rates of treatments, and increasing healthcare expenditure. Growing awareness about fertility options and supportive government initiatives are encouraging more individuals to seek treatment. Additionally, the expansion of fertility clinics and the availability of advanced diagnostic tools are contributing to market growth.

In the future, the market is expected to witness continued innovation in reproductive medicine, including personalized treatment approaches and genetic screening technologies. Increasing social acceptance and reduced stigma around infertility will further boost demand. Expansion into emerging markets and improvements in affordability will play a crucial role in growth. The infertility treatment market is expected to grow significantly in the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

  • Equipment (Microscopes, Imaging Systems, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulator Systems, Incubators, Gas Analyzers, Laser Systems, Cryosystems, Sperm Separation Devices)
  • Media & Consumables
  • Accessories

By Procedure

  • Assisted Reproductive Technology
  • Artificial Insemination
  • Fertility Surgeries
  • Other Infertility Treatment Procedures

By Patient Type

  • Female Infertility Treatment
  • Male Infertility Treatment

By End User

  • Fertility Centers
  • Hospitals & Surgical Clinics
  • Cryobanks
  • Research Institutes

COMPANIES PROFILED

  • The Cooper Companies Inc., Cook Group, Vitrolife, Thermo Fisher Scientific Inc., Esco Micro Pte. Ltd., Genea Biomedx, IVFtech ApS, FUJIFILM Irvine Scientific, The Baker Company Inc., Kitazato Corporation, Rocket Medical plc, IHMedical A/S, Hamilton Thorne Ltd., ZEISS Group, MedGyn Products Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL INFERTILITY TREATMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Equipment (Microscopes, Imaging Systems, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulator Systems, Incubators, Gas Analyzers, Laser Systems, Cryosystems, Sperm Separation Devices) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Media & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INFERTILITY TREATMENT MARKET: BY PROCEDURE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Procedure
  • 5.2. Assisted Reproductive Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Artificial Insemination Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Fertility Surgeries Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Other Infertility Treatment Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INFERTILITY TREATMENT MARKET: BY PATIENT TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Patient Type
  • 6.2. Female Infertility Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Male Infertility Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INFERTILITY TREATMENT MARKET: BY END USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End User
  • 7.2. Fertility Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Hospitals & Surgical Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Cryobanks Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL INFERTILITY TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Procedure
    • 8.2.3 By Patient Type
    • 8.2.4 By End User
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Procedure
    • 8.3.3 By Patient Type
    • 8.3.4 By End User
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Procedure
    • 8.4.3 By Patient Type
    • 8.4.4 By End User
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Procedure
    • 8.5.3 By Patient Type
    • 8.5.4 By End User
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Procedure
    • 8.6.3 By Patient Type
    • 8.6.4 By End User
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL INFERTILITY TREATMENT INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 The Cooper Companies Inc
    • 10.2.2 Cook Group
    • 10.2.3 Vitrolife
    • 10.2.4 Thermo Fisher Scientific Inc
    • 10.2.5 Esco Micro Pte. Ltd
    • 10.2.6 Genea Biomedx
    • 10.2.7 IVFtech ApS
    • 10.2.8 FUJIFILM Irvine Scientific
    • 10.2.9 The Baker Company Inc
    • 10.2.10 Kitazato Corporation
    • 10.2.11 Rocket Medical Plc
    • 10.2.12 IHMedical A/S
    • 10.2.13 Hamilton Thorne Ltd
    • 10.2.14 ZEISS Group
    • 10.2.15 MedGyn Products Inc